MedTrace Logo

The Individualized Behavioral Intervention of Smartphone App in the Treatment of Type 2 Diabetes Mellitus

NCT03061851 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2017-02-23

No results posted yet for this study

Summary

The patients with type 2 diabetes who underwent routine hypoglycemic agents and insulin therapy were evaluated for 48 weeks with maltose software.

Conditions

  • Diabetes Mellitus, Type 2

Interventions

BEHAVIORAL

conventional treatment

the treatment plan by the investigators according to the patient's condition may be, this study does not interfere.

OTHER

Maltose app

1. Weekly diabetes-related science articles. 2. Patients reported hypoglycemia or other adverse reactions, the competent physician to deal with. 3. Questionnaires published out the hospital (2 weeks 1), the feedback for the problem. 4. monitoring of abnormal blood glucose data or the presence of related discomfort, can communicate with the competent physician online. 5. Personalize the development of diet, exercise program. 6. different insulin and oral hypoglycemic drug medication time to remind. 7. hypoglycemic drug side effects query.

Sponsors & Collaborators

  • H & J CRO International, Inc.

    collaborator INDUSTRY

  • Qingdao Zhixin Health Technology Co., Ltd.

    lead OTHER

Principal Investigators

  • Jian Wang · Qingdao Zhixin Health Technology Co., Ltd.

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-25
Primary Completion
2018-08-31
Completion
2018-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03061851 on ClinicalTrials.gov